Ataxin 2 (ATXN2) Peptide
ATXN2
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN939080
Quick Overview for Ataxin 2 (ATXN2) Peptide (ABIN939080)
Target
Ataxin 2 (ATXN2)
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- HAPMMLMTTQ PPGGPQAALA QSALQPIPVS TTAHFPYMTH PSVQAHHQQQ
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ATXN2 antibody,
Alternative Names: ATXN2 control peptide, ATXN2 antibody Blocking Peptide, Anti-ATXN2 Blocking Peptide, ataxin 2 Blocking Peptide, ATX2 Blocking Peptide, FLJ46772 Blocking Peptide, SCA2 Blocking Peptide, TNRC13 Blocking Peptide, ATXN2, ATXN-2, ATXN 2, ATXN-2 Blocking Peptide, ATXN 2 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- Ataxin 2 (ATXN2)
-
Background
- The autosomal dominant cerebellar ataxias (ADCA) are a heterogeneous group of neurodegenerative disorders characterized by progressive degeneration of the cerebellum, brain stem and spinal cord. Clinically, ADCA has been divided into three groups: ADCA ty.
-
Molecular Weight
- 140 kDa
Target
-
You are here:
